Nanotechnology Applications for the Diagnosis and Therapeutic Treatment of Fungal Diseases
- 1st Edition - January 1, 2026
- Imprint: Academic Press
- Editors: Virendra Gajbhiye, Vandana Ghormade, Jay Babu Ramapuram
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 9 2 7 3 - 6
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 9 2 7 4 - 3
Nanotechnology Applications for the Diagnosis and Therapeutic Treatment of Fungal Diseases offers comprehensive coverage of the fundamentals of fungal diseases and the applic… Read more
Purchase options
Nanotechnology Applications for the Diagnosis and Therapeutic Treatment of Fungal Diseases offers comprehensive coverage of the fundamentals of fungal diseases and the applications of nanotechnology for their diagnosis and treatment. The book discusses the basics of human fungal pathogens and molecular basis of infection, antifungal drugs and their mechanism of action, application of nanoparticles in the delivery of antifungal agents and their roles in nanotechnology-based products for treatment of the fungal diseases, application of nanoparticles for the delivery of antifungal agents and their role in the treatment of various fungal diseases. It also explores various nanotechnology-based products as well as the current and future applications of nano-methodologies and technologies in the field of fungal infectious diseases. With contributions from experts in the field, Nanotechnology Applications for the Diagnosis and Therapeutic Treatment of Fungal Diseases is an informative tool for scientists, researchers, and medical personnel better understand fungal diseases in order to design and develop novel and accessible nano-based therapies for them.
- Provide comprehensive knowledge of human fungal pathogens and their molecular level of infection
- Emphasize the molecular mechanism of antifungal agents and nanotechnology-based delivery of these agents to treat various fungal diseases
- Elucidates the role of nano-based methodology such as nano-biofilm nanogels for the fungal treatment
Researchers and scientists in microbiology, biotechnology, and pharmaceutical science as well as medical personnel involved in the development of advanced techniques and methods for diagnosis and treatment of various diseases
Part I: Introduction to Fungal Diseases, current diagnostic strategies and treatment regimes
1. Fungal infections in humans and aspects of various human fungal pathogens
2. Molecular basis of the fungal infection and pathogenesis
3. Anti-fungal drugs, resistance towards them and their mechanisms
4. Conventional approaches for diagnosis and treatment of fungal diseases
Part II: Nanotechnology-based detection of fungal diseases
5. Current nanotechnology approaches for identification and diagnosis of human fungal pathogens
6. Biosensors and biomarkers for detection of Human pathogenic fungus
7. Recent approaches in Point-Of-Care-Tests (POCTS) for fungal pathogens
Part III: Nanotechnology-based treatment of fungal diseases
8. Current scenario of anti-fungal resistance and the drugs in the pipeline
9. Candidiasis infection and nano-therapeutic strategies for treatment
10. Nanoparticles as a cure for Aspergillosis
11. Nanoparticles for the treatment of Cryptococcosis, Histoplasmosis, Coccidioidomycosis and Pneumocystis pneumonia treatment
12. Nanogel: Cure for fungal diseases
13. Nanoparticles remedies for the cure of cutaneous fungal infections
14. In response to COVID-19 pandemic: Nanomedicine preparedness for Mucormycosis and Aspergillosis treatment
15. Nanoparticle based drugs for ocular fungal diseases
1. Fungal infections in humans and aspects of various human fungal pathogens
2. Molecular basis of the fungal infection and pathogenesis
3. Anti-fungal drugs, resistance towards them and their mechanisms
4. Conventional approaches for diagnosis and treatment of fungal diseases
Part II: Nanotechnology-based detection of fungal diseases
5. Current nanotechnology approaches for identification and diagnosis of human fungal pathogens
6. Biosensors and biomarkers for detection of Human pathogenic fungus
7. Recent approaches in Point-Of-Care-Tests (POCTS) for fungal pathogens
Part III: Nanotechnology-based treatment of fungal diseases
8. Current scenario of anti-fungal resistance and the drugs in the pipeline
9. Candidiasis infection and nano-therapeutic strategies for treatment
10. Nanoparticles as a cure for Aspergillosis
11. Nanoparticles for the treatment of Cryptococcosis, Histoplasmosis, Coccidioidomycosis and Pneumocystis pneumonia treatment
12. Nanogel: Cure for fungal diseases
13. Nanoparticles remedies for the cure of cutaneous fungal infections
14. In response to COVID-19 pandemic: Nanomedicine preparedness for Mucormycosis and Aspergillosis treatment
15. Nanoparticle based drugs for ocular fungal diseases
- Edition: 1
- Published: January 1, 2026
- Imprint: Academic Press
- Language: English
VG
Virendra Gajbhiye
Dr. Virendra Gajbhiye has been working in the field of nanomedicine for the last 15 years. He has a doctoral degree (Ph.D.) in Pharmaceutical Science with post-doctoral research experience at University of Wisconsin-Madison and Oregon Health and Sciences University. Since 2013 he is working as a Scientist in Nanomedicine at Agharkar Research Institute, Pune, India. He has worked extensively with polymeric nanoparticles specially dendrimers and mesoporous silica nanoparticles. His research interest lies in Nanomedicine, Targeted drug and siRNA delivery, Biomedical application of dendrimers, Biomaterials unimolecular micelles and imaging, Multifunctional polymeric nanoparticles, Nanoparticles in tissue engineering.
Affiliations and expertise
Scientist in Nanomedicine, Agharkar Research Institute, Pune, IndiaVG
Vandana Ghormade
Vandana Ghormade’s priority research area includes the development of biosensors for pathogens and contamination detection, where nanotechnology can play a vital role. Her keen interest in paper-based detection platforms has led to the development of rapid on-site detection of human invasive aspergillosis and ochratoxin. Nanoparticles as sensitive signaling labels, in combination with antibodies, can be used to develop Lateral Flow assay or ELISA formats. The development of nanotechnology-based rapid diagnostics will help alleviate the increasing disease incidences in India by allowing timely treatment to patients.
Affiliations and expertise
Nanobioscience Group, Agharkar Research Institute, IndiaJR
Jay Babu Ramapuram
Jay Babu Ramapuram, PhD, is currently a Professor and Graduate Program Officer at the Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University. He received his Bachelor of Pharmacy from the University of Madras and Master of Pharmacy and PhD degrees in Pharmaceutics from the Indian Institute of Technology, Varanasi, India. He has over 24 years of academic and industry experience in formulation and drug delivery research. His research interests include nanotechnology based topical formulations for skin diseases, lipid-based nanomedicines for cancer treatment, formulation of 3d printed implants, nanotechnology approaches for solubility and bioavailability improvement. He has published over 90 peer-reviewed manuscripts, 13 book chapters, and has presented over 100 papers in various national and international conferences.
Affiliations and expertise
Professor and Graduate Program Officer, Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, Alabama, USA